ABOUT US Mission and Objectives Message from the Chairman Message from the Secretary General Who Are We? Board of Directors Our Members Inspection Board Committees Pharmacovigilance Committee Intellectual Property Rights Committee GCP Committee Reimbursement Committee GPP Committee OTC (Non-Prescription Drugs) Committee PR Committee Regulatory Affairs Committee Anti-Counterfeiting Committee Charter Name of the Association Head Office Mission and Activities of the Association Membership Terms of Joining and Terminating Bodies of the Association General Assembly Board of Directors Inspection Board Internal Audit Secretary General Acquisition of Property Revenues and Expenditures of the Assoc. Dissolution of the Association Records of the Association Charter Amendments Absence of Ruling Applicable Language Founders of the Association Code of Promotion Position Documents SECTORIAL DATA Announcements of Moh & Legislation Frequently Asked Questions NEW DRUGS AND R&D What does it mean to be researcher? What is an “Original” drug? Implementations (Original & Generic) Patent Protection Data Exclusivity PRESS ROOM Press Announcement Press Releases News Insider AİFD Activities Reflections in the Press RESEARCHES AND PUBLICATIONS AIFD ACADEMY About AİFD Academy AİFD Academy Final Declaration Scientific Advisory Board AİFD Academy E-Bulletin Membership TR EN     Home Page » ABOUT US » Charter Charter Name of the Association Head Office Mission and Activities of the Association Membership Terms of Joining and Terminating Bodies of the Association General Assembly Board of Directors Inspection Board Internal Audit Secretary General Acquisition of Property Revenues and Expenditures of the Assoc. Dissolution of the Association Records of the Association Charter Amendments Absence of Ruling Applicable Language Founders of the Association Mission and Objectives Message from the Chairman Message from the Secretary General Who Are We? Board of Directors Our Members Inspection Board Committees Pharmacovigilance Committee Intellectual Property Rights Committee GCP Committee Reimbursement Committee GPP Committee OTC (Non-Prescription Drugs) Committee PR Committee Regulatory Affairs Committee Anti-Counterfeiting Committee Charter Name of the Association Head Office Mission and Activities of the Association Membership Terms of Joining and Terminating Bodies of the Association General Assembly Board of Directors Inspection Board Internal Audit Secretary General Acquisition of Property Revenues and Expenditures of the Assoc. Dissolution of the Association Records of the Association Charter Amendments Absence of Ruling Applicable Language Founders of the Association Code of Promotion Position Documents MEMBER LOGIN INSIDER AİFD Right strategies will lead Turkey to a bright future SEARCH IN SITE DID YOU KNOW THAT…? IMPORTANT TERMS SITE MAP USEFUL LINKS CONFIDENTIALITY-TERMS OF USE CONTACT Abbott • Actelion • Alcon • Alexion İlaç Ticaret Ltd. Şti. • Amgen • Astellas • AstraZeneca • Bayer Türk Kimya San. Ltd. Şti. • Boehringer İngelheim • Bristol-Myers Squibb • Celgene • Chiesi • Daiichi-Sankyo • Eczacıbaşı-Baxter • Ferring • Fresenius Kabi • Fresenius Medical Care • Genzyme Sağlık Hizmetleri ve Tedavi Ürünleri Tic.Ltd.Şti. • Gilead Sciences İlaç.Tic. Ltd. Şti. • GlaxoSmithKline • IBSA İlaç San. ve Tic. Ltd. Şti. • Intendis • İ.E.Ulagay • Johnson&Johnson • Lilly • Lundbeck • Merck Serono • MSD Türkiye • Nestle • Novartis Sağlık Ürünleri • Novo Nordisk • Nutricia Klinik Beslenme • Pfizer İlaçları Ltd. Şti • Roche Müstahzarları San. A.Ş. • Sanofi-aventis • Servier • U.C.B. Pharma • Wyeth İlaçları Limited Şirketi • AİFD is a member of IFPMA – International Federation of Pharmaceutical Manufacturers and Associations and EFPIA (European Federation of Pharmaceutical Industries and Associations).     © Association of Research-Based Pharmaceutical Companies Last Update : 03.09.2010